ABZENA (UK) LIMITED

Company Number		04295642
Company ID Number		04295642
Date formed		2001-09-28
Country
Origin Country		United Kingdom
Type		Private Limited Company
CompanyStatus		Active
Lastest accounts		31/12/2022
Account next due		30/09/2024
Latest return		15/06/2016
Return next due		13/07/2017
Type of accounts		AUDIT EXEMPTION SUBSIDIARY

Is this data useful to you?

If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help.
Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.

Company Officers of ABZENA (UK) LIMITED

Current Directors

Officer	Role	Date Appointed
JULIAN MATTHEW SMITH	Company Secretary	2013-09-26
CAMPBELL BUNCE	Director	2016-10-25
WILLIAM JOHN EDWARD BURT	Director	2011-05-26
JAMES MILLS	Director	2016-11-01
JULIAN MATTHEW SMITH	Director	2013-08-26

Previous Officers

Officer	Role	Date Appointed	Date Resigned
SALLY CHRISTINA WATERMAN	Director	2015-08-13	2016-11-03
KENNETH THOMAS CUNNINGHAM	Director	2010-04-29	2014-06-05
ANTHONY DAVID BRAMPTON	Director	2007-06-15	2014-05-23
ANKER LUNDEMOSE	Director	2012-05-01	2014-05-23
MERCIA FUND MANAGEMENT (NOMINEES) LTD	Director	2012-03-29	2014-05-23
STEPHANE MERY	Director	2011-09-05	2014-05-23
NIGEL AARON PITCHFORD	Director	2012-02-07	2014-05-23
SALLY CHRISTINA WATERMAN	Company Secretary	2010-11-10	2013-09-26
STEPHEN JAMES BROCCHINI	Director	2007-06-15	2012-12-11
MARK ANDREW PAYTON	Director	2012-02-07	2012-03-31
ROBERT HAROLD BAHNS	Director	2010-02-16	2012-02-07
MICHAEL VICTOR HAYES	Director	2007-06-15	2012-01-31
KEITH ADRIAN POWELL	Director	2005-05-08	2011-05-25
TIMOTHY DAVID BROWN	Company Secretary	2008-01-31	2010-11-10
SIMON GEOFFREY BEST	Director	2008-09-25	2010-03-31
TILL MEDINGER	Director	2006-03-01	2010-02-16
STEPHANE ROBERT GEORGE MERY	Director	2007-06-15	2010-02-16
JOHN WILKINSON	Company Secretary	2001-09-28	2008-01-31
ROBERT HAROLD BAHNS	Director	2005-11-30	2007-06-15
WILLIAM LINDSAY	Director	2006-03-01	2007-06-15
ALAN BENJAMIN SANDERS	Director	2001-11-01	2007-01-25
STEPHEN JAMES BROCCHINI	Director	2001-11-01	2006-03-03
SUNIL SHAUNAK	Director	2001-09-28	2006-03-01
STEPHANE ROBERT GEORGE MERY	Director	2002-08-12	2005-05-08
DIMITRI DIMITRIOU	Director	2001-11-01	2002-05-28
DAVID MARK ANTHONY HOLBROOK	Director	2001-11-01	2002-01-23
SWIFT INCORPORATIONS LIMITED	Nominated Secretary	2001-09-28	2001-09-28
INSTANT COMPANIES LIMITED	Nominated Director	2001-09-28	2001-09-28

Related Directorships

Officer	Related Company	Role	Date Appointed	Role Status	Incorporation date	Company Status
CAMPBELL BUNCE	ABZENA (CAMBRIDGE) LIMITED	Director	2016-10-25	CURRENT	2004-12-21	Active
CAMPBELL BUNCE	WARWICK EFFECT POLYMERS LIMITED	Director	2016-10-25	CURRENT	2001-03-19	Active - Proposal to Strike off
CAMPBELL BUNCE	DENCEPTOR THERAPEUTICS LIMITED	Director	2016-07-13	CURRENT	2015-06-29	Active - Proposal to Strike off
CAMPBELL BUNCE	TUIG R&D SERVICES LIMITED	Director	2008-11-28	CURRENT	2008-11-28	Dissolved 2015-08-25
WILLIAM JOHN EDWARD BURT	ABZENA HOLDINGS LIMITED	Director	2015-06-26	CURRENT	2015-06-26	Active - Proposal to Strike off
WILLIAM JOHN EDWARD BURT	ABZENA LIMITED	Director	2014-03-25	CURRENT	2014-03-25	Active
WILLIAM JOHN EDWARD BURT	ABZENA (CAMBRIDGE) LIMITED	Director	2013-07-25	CURRENT	2004-12-21	Active
WILLIAM JOHN EDWARD BURT	ASHENDUN LIMITED	Director	2009-06-24	CURRENT	2009-06-24	Active
JAMES MILLS	ABZENA (CAMBRIDGE) LIMITED	Director	2016-11-01	CURRENT	2004-12-21	Active
JAMES MILLS	WARWICK EFFECT POLYMERS LIMITED	Director	2016-11-01	CURRENT	2001-03-19	Active - Proposal to Strike off
JAMES MILLS	ABZENA HOLDINGS LIMITED	Director	2016-11-01	CURRENT	2015-06-26	Active - Proposal to Strike off
JULIAN MATTHEW SMITH	DENCEPTOR THERAPEUTICS LIMITED	Director	2015-07-29	CURRENT	2015-06-29	Active - Proposal to Strike off
JULIAN MATTHEW SMITH	ABZENA HOLDINGS LIMITED	Director	2015-06-26	CURRENT	2015-06-26	Active - Proposal to Strike off
JULIAN MATTHEW SMITH	ABZENA LIMITED	Director	2014-03-26	CURRENT	2014-03-25	Active
JULIAN MATTHEW SMITH	ABZENA (CAMBRIDGE) LIMITED	Director	2013-09-26	CURRENT	2004-12-21	Active
JULIAN MATTHEW SMITH	WARWICK EFFECT POLYMERS LIMITED	Director	2013-09-26	CURRENT	2001-03-19	Active - Proposal to Strike off

More director information

Corporation Filing History

Companies House Filing History

This is a record of the public documents (corporate filing) lodged from Companies House where the company has filed annual returns and other statutory filing documents. Examples of documents filed include: change of registered office, accounts filing, director/officer appointments & resignations, changes in share capital, shareholder members lists etc.

Date	Document Type	Document Description
2024-03-21		CONFIRMATION STATEMENT MADE ON 19/03/24, WITH NO UPDATES
2023-10-14		Notice of agreement to exemption from audit of accounts for period ending 31/12/22
2023-10-14		Audit exemption statement of guarantee by parent company for period ending 31/12/22
2023-10-14		Consolidated accounts of parent company for subsidiary company period ending 31/12/22
2023-10-14		Audit exemption subsidiary accounts made up to 2022-12-31
2023-06-16		APPOINTMENT TERMINATED, DIRECTOR KEVIN MICHAEL LUNDQUIST
2023-06-16		DIRECTOR APPOINTED MR THOMAS PAUL CASTELLANO
2023-03-27		CONFIRMATION STATEMENT MADE ON 19/03/23, WITH NO UPDATES
2023-03-27		CONFIRMATION STATEMENT MADE ON 19/03/23, WITH NO UPDATES
2022-12-23		DIRECTOR APPOINTED MR MATTHEW ROBERT STOBER
2022-12-23		APPOINTMENT TERMINATED, DIRECTOR GEOFFREY MICHAEL GLASS
2022-09-27		Audit exemption statement of guarantee by parent company for period ending 31/12/21
2022-09-27		Notice of agreement to exemption from audit of accounts for period ending 31/12/21
2022-09-27		Consolidated accounts of parent company for subsidiary company period ending 31/12/21
2022-09-27		Audit exemption subsidiary accounts made up to 2021-12-31
2022-09-27	PARENT_ACC	Consolidated accounts of parent company for subsidiary company period ending 31/12/21
2022-09-27	AGREEMENT2	Notice of agreement to exemption from audit of accounts for period ending 31/12/21
2022-09-27	GUARANTEE2	Audit exemption statement of guarantee by parent company for period ending 31/12/21
2022-03-21	CS01	CONFIRMATION STATEMENT MADE ON 19/03/22, WITH NO UPDATES
2022-02-24	AP01	DIRECTOR APPOINTED MR KEVIN MICHAEL LUNDQUIST
2022-02-11		APPOINTMENT TERMINATED, DIRECTOR RICHARD HENRY JOHN MILBANK
2022-02-11	TM01	APPOINTMENT TERMINATED, DIRECTOR RICHARD HENRY JOHN MILBANK
2021-09-23	PARENT_ACC	Consolidated accounts of parent company for subsidiary company period ending 31/12/20
2021-09-23	AGREEMENT2	Notice of agreement to exemption from audit of accounts for period ending 31/12/20
2021-09-23	GUARANTEE2	Audit exemption statement of guarantee by parent company for period ending 31/12/20
2021-06-09	AD03	Registers moved to registered inspection location of Highdown House Yeoman Way Worthing West Sussex BN99 3HH
2021-06-02	AD02	Register inspection address changed from Elder House St Georges Business Park 207 Brooklands Road Weybridge Surrey KT13 0TS United Kingdom to Highdown House Yeoman Way Worthing West Sussex BN99 3HH
2021-05-19	MR04	STATEMENT OF SATISFACTION OF A CHARGE / FULL / CHARGE CODE 042956420001
2021-03-19	CS01	CONFIRMATION STATEMENT MADE ON 19/03/21, WITH UPDATES
2020-10-12	PARENT_ACC	Consolidated accounts of parent company for subsidiary company period ending 31/12/19
2020-10-12	AGREEMENT2	Notice of agreement to exemption from audit of accounts for period ending 31/12/19
2020-10-12	GUARANTEE2	Audit exemption statement of guarantee by parent company for period ending 31/12/19
2020-04-29	SH01	17/04/20 STATEMENT OF CAPITAL GBP 13157.879
2020-04-01	CS01	CONFIRMATION STATEMENT MADE ON 19/03/20, WITH UPDATES
2020-04-01	SH01	27/02/20 STATEMENT OF CAPITAL GBP 13157.878
2020-01-06	PARENT_ACC	Consolidated accounts of parent company for subsidiary company period ending 31/03/19
2020-01-06	AGREEMENT2	Notice of agreement to exemption from audit of accounts for period ending 31/03/19
2020-01-06	GUARANTEE2	Audit exemption statement of guarantee by parent company for period ending 31/03/19
2020-01-06	AA01	Previous accounting period shortened from 31/03/20 TO 31/12/19
2020-01-04	AGREEMENT2	Notice of agreement to exemption from audit of accounts for period ending 31/03/19
2020-01-04	GUARANTEE2	Audit exemption statement of guarantee by parent company for period ending 31/03/19
2019-12-09	SH01	27/11/19 STATEMENT OF CAPITAL GBP 13157.877
2019-11-08	TM01	APPOINTMENT TERMINATED, DIRECTOR NICHOLAS O'LEARY
2019-08-16	MR01	REGISTRATION OF A CHARGE / CHARGE CODE 042956420001
2019-07-30	SH01	24/07/19 STATEMENT OF CAPITAL GBP 13157.876
2019-03-29	CS01	CONFIRMATION STATEMENT MADE ON 19/03/19, WITH UPDATES
2019-01-24	RES15	CHANGE OF COMPANY NAME 02/06/21
2018-12-21	RES15	CHANGE OF COMPANY NAME 02/06/21
2018-12-21	CONNOT	NOTICE OF CHANGE OF NAME NM01 - RESOLUTION
2018-11-23	AP01	DIRECTOR APPOINTED MR RICHARD HENRY JOHN MILBANK
2018-11-21	AD03	Registers moved to registered inspection location of Elder House St Georges Business Park 207 Brooklands Road Weybridge Surrey KT13 0TS
2018-11-21	AD02	Register inspection address changed from 42-50 Hersham Road Walton-on-Thames Surrey KT12 1RZ United Kingdom to Elder House St Georges Business Park 207 Brooklands Road Weybridge Surrey KT13 0TS
2018-11-19	TM01	APPOINTMENT TERMINATED, DIRECTOR JAMES MILLS
2018-10-23	PSC05	Change of details for Abzena Plc as a person with significant control on 2018-10-22
2018-10-17	AP01	DIRECTOR APPOINTED MR JONATHAN GOLDMAN
2018-10-03	MEM/ARTS	ARTICLES OF ASSOCIATION
2018-10-03	RES01	ADOPT ARTICLES 03/10/18
2018-09-24	TM02	Termination of appointment of Julian Matthew Smith on 2018-09-21
2018-09-24	AP03	Appointment of Mrs Michelle Dawn Neaves as company secretary on 2018-09-21
2018-09-24	TM01	APPOINTMENT TERMINATED, DIRECTOR JULIAN MATTHEW SMITH
2018-09-24	AP01	DIRECTOR APPOINTED MRS MICHELLE DAWN NEAVES
2018-09-19	MEM/ARTS	ARTICLES OF ASSOCIATION
2018-09-19	RES01	ADOPT ARTICLES 19/09/18
2018-08-30	AA	FULL ACCOUNTS MADE UP TO 31/03/18
2018-03-19	CS01	CONFIRMATION STATEMENT MADE ON 19/03/18, WITH NO UPDATES
2017-07-25	AA	FULL ACCOUNTS MADE UP TO 31/03/17
2017-06-18	LATEST SOC	18/06/17 STATEMENT OF CAPITAL;GBP 13157.875
2017-06-18	CS01	CONFIRMATION STATEMENT MADE ON 15/06/17, WITH UPDATES
2017-03-28	AP01	DIRECTOR APPOINTED DR CAMPBELL BUNCE
2017-03-28	AP01	DIRECTOR APPOINTED MR JAMES MILLS
2017-02-21	TM01	APPOINTMENT TERMINATED, DIRECTOR SALLY WATERMAN
2017-01-07	AA	FULL ACCOUNTS MADE UP TO 31/03/16
2016-07-11	LATEST SOC	11/07/16 STATEMENT OF CAPITAL;GBP 13157.875
2016-07-11	AR01	15/06/16 FULL LIST
2016-03-29	CH01	DIRECTOR'S CHANGE OF PARTICULARS / DR SALLY CHRISTINA WATERMAN / 15/03/2016
2016-01-06	AA	FULL ACCOUNTS MADE UP TO 31/03/15
2015-10-07	LATEST SOC	07/10/15 STATEMENT OF CAPITAL;GBP 13157.875
2015-10-07	AR01	28/09/15 FULL LIST
2015-08-14	AP01	DIRECTOR APPOINTED DR SALLY CHRISTINA WATERMAN
2015-04-10	AD03	REGISTER(S) MOVED TO SAIL ADDRESS 114-REG MEM 162-REG DIR 275-REG SEC
2015-03-24	AD02	SAIL ADDRESS CREATED
2015-01-20	AAMD	AMENDED GROUP OF COMPANIES' ACCOUNTS MADE UP TO 31/03/14
2014-09-29	LATEST SOC	29/09/14 STATEMENT OF CAPITAL;GBP 13157.875
2014-09-29	AR01	28/09/14 FULL LIST
2014-07-11	AA	FULL ACCOUNTS MADE UP TO 31/03/14
2014-07-04	AD01	REGISTERED OFFICE CHANGED ON 04/07/2014 FROM C/O POLYTHERICS LTD THE LONDON BIOSCIENCE INNOVATION CENTRE 2 ROYAL COLLEGE STREET LONDON NW1 0NH
2014-06-24	SH20	STATEMENT BY DIRECTORS
2014-06-24	CAP-SS	SOLVENCY STATEMENT DATED 23/06/14
2014-06-24	SH19	24/06/14 STATEMENT OF CAPITAL GBP 13157.874
2014-06-24	RES13	CANCELLATION OF SHARE PREMIUM ACCOUNT 23/06/2014
2014-06-19	CH01	DIRECTOR'S CHANGE OF PARTICULARS / DR WILLIAM JOHN EDWARD BURT / 13/06/2014
2014-06-19	CH03	SECRETARY'S CHANGE OF PARTICULARS / MR JULIAN MATTHEW SMITH / 13/06/2014
2014-06-19	CH01	DIRECTOR'S CHANGE OF PARTICULARS / MR JULIAN MATTHEW SMITH / 13/06/2014
2014-06-13	TM01	APPOINTMENT TERMINATED, DIRECTOR STEPHANE MERY
2014-06-11	TM01	APPOINTMENT TERMINATED, DIRECTOR KENNETH CUNNINGHAM
2014-06-11	CH01	DIRECTOR'S CHANGE OF PARTICULARS / MR NIGEL AARON PITCHFORD / 01/01/2013
2014-06-11	CH01	DIRECTOR'S CHANGE OF PARTICULARS / ANKER LUNDEMOSE / 01/01/2013
2014-06-10	TM01	APPOINTMENT TERMINATED, DIRECTOR MERCIA FUND MANAGEMENT (NOMINEES) LTD
2014-06-10	TM01	APPOINTMENT TERMINATED, DIRECTOR ANKER LUNDEMOSE
2014-06-10	TM01	APPOINTMENT TERMINATED, DIRECTOR ANTHONY BRAMPTON
2014-06-10	TM01	APPOINTMENT TERMINATED, DIRECTOR NIGEL PITCHFORD
2014-05-06	SH01	29/04/14 STATEMENT OF CAPITAL GBP 13157.874
2014-03-31	SH01	17/03/14 STATEMENT OF CAPITAL GBP 13020.135
2014-03-31	SH01	20/03/14 STATEMENT OF CAPITAL GBP 13001.57
2014-03-31	SH01	25/03/14 STATEMENT OF CAPITAL GBP 13131.059
2014-03-17	SH01	30/09/13 STATEMENT OF CAPITAL GBP 12983.697
2013-12-20	AA01	CURREXT FROM 31/12/2013 TO 31/03/2014
2013-11-25	AP03	SECRETARY APPOINTED MR JULIAN MATTHEW SMITH
2013-11-14	TM02	APPOINTMENT TERMINATED, SECRETARY SALLY WATERMAN
2013-10-28	AR01	28/09/13 FULL LIST
2013-10-25	CH03	SECRETARY'S CHANGE OF PARTICULARS / DR SALLY CHRISTINA WATERMAN / 24/10/2013
2013-10-04	AP01	DIRECTOR APPOINTED MR JULIAN MATTHEW SMITH
2013-08-27	SH01	25/07/13 STATEMENT OF CAPITAL GBP 12209.691
2013-08-13	RES01	ADOPT ARTICLES 25/07/2013
2013-07-17	AA	ACCOUNTS FOR 'SMALL' CO. MADE UP TO 31/12/12
2012-12-20	TM01	APPOINTMENT TERMINATED, DIRECTOR STEPHEN BROCCHINI
2012-10-26	AR01	28/09/12 FULL LIST
2012-10-15	SH01	19/07/12 STATEMENT OF CAPITAL GBP 7583.697
2012-05-22	AP01	DIRECTOR APPOINTED ANKER LUNDEMOSE
2012-05-01	AA	ACCOUNTS FOR 'SMALL' CO. MADE UP TO 31/12/11
2012-04-23	MEM/ARTS	ARTICLES OF ASSOCIATION
2012-04-23	RES01	ALTER ARTICLES 05/04/2012
2012-04-18	AP02	CORPORATE DIRECTOR APPOINTED MERCIA FUND MANAGEMENT (NOMINEES) LTD
2012-04-17	TM01	APPOINTMENT TERMINATED, DIRECTOR MARK PAYTON
2012-04-17	SH01	05/04/12 STATEMENT OF CAPITAL GBP 7424.443
2012-03-08	SH01	19/01/12 STATEMENT OF CAPITAL GBP 7341.838
2012-02-16	AP01	DIRECTOR APPOINTED NIGEL AARON PITCHFORD
2012-02-15	AP01	DIRECTOR APPOINTED MARK ANDREW PAYTON
2012-02-14	TM01	APPOINTMENT TERMINATED, DIRECTOR ROBERT BAHNS
2012-02-09	TM01	APPOINTMENT TERMINATED, DIRECTOR MICHAEL HAYES
2011-12-21	SH01	06/12/11 STATEMENT OF CAPITAL GBP 6582.765
2011-11-09	SH01	04/11/11 STATEMENT OF CAPITAL GBP 6432.765
2011-11-01	AR01	28/09/11 FULL LIST
2011-10-13	SH01	06/10/11 STATEMENT OF CAPITAL GBP 6346.464
2011-09-21	SH10	NOTICE OF PARTICULARS OF VARIATION OF RIGHTS ATTACHED TO SHARES
2011-09-20	RES01	ADOPT ARTICLES 05/09/2011
2011-09-20	SH01	15/09/11 STATEMENT OF CAPITAL GBP 6246.464
2011-09-20	SH08	NOTICE OF NAME OR OTHER DESIGNATION OF CLASS OF SHARES
2011-09-19	AP01	DIRECTOR APPOINTED DR STEPHANE MERY
2011-07-19	AD01	REGISTERED OFFICE CHANGED ON 19/07/2011 FROM THE LONDON BIOSCIENCE INNOVATION CENTRE 2 ROYAL COLLEGE STREET LONDON NW1 0TU
2011-06-02	AP01	DIRECTOR APPOINTED DR WILLIAM JOHN EDWARD BURT
2011-05-25	TM01	APPOINTMENT TERMINATED, DIRECTOR KEITH POWELL
2011-04-01	AA	ACCOUNTS FOR 'SMALL' CO. MADE UP TO 31/12/10
2011-03-07	RES13	ART 10 & 12 NOT APPLY TO ANY ALLOTMENT OF SHARES 28/01/2011
2011-03-07	RES01	ADOPT ARTICLES 28/01/2011
2010-11-10	AP03	SECRETARY APPOINTED DR SALLY CHRISTINA WATERMAN
2010-11-10	TM02	APPOINTMENT TERMINATED, SECRETARY TIMOTHY BROWN
2010-11-01	CH01	DIRECTOR'S CHANGE OF PARTICULARS / DR KEITH ADRIAN POWELL / 01/11/2010
2010-10-26	AR01	28/09/10 FULL LIST
2010-10-26	CH01	DIRECTOR'S CHANGE OF PARTICULARS / STEPHEN JAMES BROCCHINI / 28/09/2010
2010-06-16	AP01	DIRECTOR APPOINTED DR KENNETH THOMAS CUNNINGHAM
2010-05-12	AA	ACCOUNTS FOR 'SMALL' CO. MADE UP TO 31/12/09
2010-03-31	TM01	APPOINTMENT TERMINATED, DIRECTOR SIMON BEST
2010-03-31	RES01	ALTERATION TO MEMORANDUM AND ARTICLES 16/02/2010
2010-03-30	AP01	DIRECTOR APPOINTED MR ROBERT HAROLD BAHNS
2010-03-26	TM01	APPOINTMENT TERMINATED, DIRECTOR STEPHANE MERY
2010-03-26	TM01	APPOINTMENT TERMINATED, DIRECTOR TILL MEDINGER
2009-10-30	CH01	DIRECTOR'S CHANGE OF PARTICULARS / DR MICHAEL VICTOR HAYES / 30/10/2009

Industry Information

SIC/NAIC Codes

72 - Scientific research and development

721 - Research and experimental development on natural sciences and engineering

72110 - Research and experimental development on biotechnology

Licences & Regulatory approval

We could not find any licences issued to ABZENA (UK) LIMITED or authorisation from an industry specific regulator to operate. These may not be required.

Share this page on Facebook

Risks

Legal Notices

No legal notices or events such as winding-up orders or proposals to strike-off have been issued

Fines / Sanctions

No fines or sanctions have been issued against ABZENA (UK) LIMITED

Liabilities

Mortgages / Charges

Total # Mortgages/Charges	1
Mortgages/Charges outstanding	0
Mortgages Partially Satisifed	0
Mortgages Satisfied/Paid	1

Details of Mortgagee Charges

We do not yet have the details of ABZENA (UK) LIMITED's previous or outstanding mortgage charges.

Intangible Assets

Patents

We have not found any records of ABZENA (UK) LIMITED registering or being granted any patents

Domain Names

ABZENA (UK) LIMITED owns 2 domain names.

polytherics.co.uk pegylation.co.uk

Trademarks

Trademark applications by ABZENA (UK) LIMITED

ABZENA (UK) LIMITED is the Original Applicant for the trademark EPISCREEN ™ (86716415) through the USPTO on the 2015-08-06: Pharmaceuticals; Pharmaceutical compositions; Pharmaceutical preparations; Chemical preparations for medical or pharmaceutical purposes; Chemico-pharmaceutical preparations; Chemicals for pharmaceutical use; Vaccines; Pharmaceutical preparations for skin care
ABZENA (UK) LIMITED is the Owner at publication for the trademark THIOBRIDGE ™ (85775260) through the USPTO on the 2012-11-08: (Based on Intent to Use) Chemical preparations for use as pharmaceutical intermediates; chemical preparations for use in the manufacture of pharmaceuticals; diagnostic reagents for scientific use; reagents for scientific purposes

Income

Government Income

We have not found government income sources for ABZENA (UK) LIMITED. This could be because the transaction value was below £ 500 with local government or below £ 25,000 for central government. We have found 8,000 supplier to government that are UK companies so approx 0.2% of companies listed on Datalog supply to government.

The top companies supplying to UK government with the same SIC code (72110 - Research and experimental development on biotechnology) as ABZENA (UK) LIMITED are:

Outgoings

Business Rates/Property Tax

No properties were found where ABZENA (UK) LIMITED is liable for the business rates / property tax. This could be for a number of reasons.

The council hasnt published the data
We havent found or been able to process the councils data
The company is part of a group of companies and another company in the group is liable for business rates
The registered office may be a residential address which does not have a commercial designation. If the business is run from home then it won't be a commercial property and hence won't be liable for business rates.
Serviced offices are increasingly popular and therefore a business may not be paying business rates directly - the building owner is and this is incorporated in the office rental charge.

Import/Export of Goods

Goods imported/exported by ABZENA (UK) LIMITED

Date	Import Code	Imported Goods classification description
2017-02-00	84131900	Pumps for liquids, fitted or designed to be fitted with a measuring device (excl. pumps for dispensing fuel or lubricants, of the type used in filling stations or in garages)
2016-11-00	30029090	Toxins and similar products, e.g. plasmodia (excl. vaccines and cultures of micro-organisms)
2016-11-00	39269097	Articles of plastics and articles of other materials of heading 3901 to 3914, n.e.s.
2016-09-00	85258019	Television cameras (excl. those with 3 or more camera tubes and video recorders)
2016-06-00	30049000	Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic purposes, put up in measured doses "incl. those in the form of transdermal administration" or in forms or packings for retail sale (excl. medicaments containing antibiotics, medicaments containing hormones or steroids used as hormones, but not containing antibiotics, medicaments containing alkaloids or derivatives thereof but not containing hormones or antibiotics and medicaments containing provitamins, vitamins
2016-05-00	29241900	Acyclic amides, incl. acyclic carbamates, and their derivatives, and salts thereof (excl. meprobamate [INN], fluoroacetamide [ISO], monocrotophos [ISO] and phosphamidon [ISO])
2016-05-00	30049000	Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic purposes, put up in measured doses "incl. those in the form of transdermal administration" or in forms or packings for retail sale (excl. medicaments containing antibiotics, medicaments containing hormones or steroids used as hormones, but not containing antibiotics, medicaments containing alkaloids or derivatives thereof but not containing hormones or antibiotics and medicaments containing provitamins, vitamins
2016-04-00	29241900	Acyclic amides, incl. acyclic carbamates, and their derivatives, and salts thereof (excl. meprobamate [INN], fluoroacetamide [ISO], monocrotophos [ISO] and phosphamidon [ISO])
2016-03-00	34042000	Poly"oxyethylene" [polyethylene glycol] waxes
2016-01-00	29241900	Acyclic amides, incl. acyclic carbamates, and their derivatives, and salts thereof (excl. meprobamate [INN], fluoroacetamide [ISO], monocrotophos [ISO] and phosphamidon [ISO])
2015-12-00	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2015-11-00	29241900	Acyclic amides, incl. acyclic carbamates, and their derivatives, and salts thereof (excl. meprobamate [INN], fluoroacetamide [ISO], monocrotophos [ISO] and phosphamidon [ISO])
2015-10-00	29241900	Acyclic amides, incl. acyclic carbamates, and their derivatives, and salts thereof (excl. meprobamate [INN], fluoroacetamide [ISO], monocrotophos [ISO] and phosphamidon [ISO])
2015-09-00	29241900	Acyclic amides, incl. acyclic carbamates, and their derivatives, and salts thereof (excl. meprobamate [INN], fluoroacetamide [ISO], monocrotophos [ISO] and phosphamidon [ISO])
2015-08-00	29241900	Acyclic amides, incl. acyclic carbamates, and their derivatives, and salts thereof (excl. meprobamate [INN], fluoroacetamide [ISO], monocrotophos [ISO] and phosphamidon [ISO])
2015-08-00	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2015-07-01	29241900	Acyclic amides, incl. acyclic carbamates, and their derivatives, and salts thereof (excl. meprobamate [INN], fluoroacetamide [ISO], monocrotophos [ISO] and phosphamidon [ISO])
2015-07-01	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2015-07-00	29241900	Acyclic amides, incl. acyclic carbamates, and their derivatives, and salts thereof (excl. meprobamate [INN], fluoroacetamide [ISO], monocrotophos [ISO] and phosphamidon [ISO])
2015-07-00	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2015-06-01	29241900	Acyclic amides, incl. acyclic carbamates, and their derivatives, and salts thereof (excl. meprobamate [INN], fluoroacetamide [ISO], monocrotophos [ISO] and phosphamidon [ISO])
2015-06-00	29241900	Acyclic amides, incl. acyclic carbamates, and their derivatives, and salts thereof (excl. meprobamate [INN], fluoroacetamide [ISO], monocrotophos [ISO] and phosphamidon [ISO])
2015-05-01	29241900	Acyclic amides, incl. acyclic carbamates, and their derivatives, and salts thereof (excl. meprobamate [INN], fluoroacetamide [ISO], monocrotophos [ISO] and phosphamidon [ISO])
2015-05-00	29241900	Acyclic amides, incl. acyclic carbamates, and their derivatives, and salts thereof (excl. meprobamate [INN], fluoroacetamide [ISO], monocrotophos [ISO] and phosphamidon [ISO])
2015-04-01	29241900	Acyclic amides, incl. acyclic carbamates, and their derivatives, and salts thereof (excl. meprobamate [INN], fluoroacetamide [ISO], monocrotophos [ISO] and phosphamidon [ISO])
2015-04-01	34042000	Poly"oxyethylene" [polyethylene glycol] waxes
2015-04-01	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2015-04-00	29241900	Acyclic amides, incl. acyclic carbamates, and their derivatives, and salts thereof (excl. meprobamate [INN], fluoroacetamide [ISO], monocrotophos [ISO] and phosphamidon [ISO])
2015-04-00	34042000	Poly"oxyethylene" [polyethylene glycol] waxes
2015-04-00	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2015-03-01	29241900	Acyclic amides, incl. acyclic carbamates, and their derivatives, and salts thereof (excl. meprobamate [INN], fluoroacetamide [ISO], monocrotophos [ISO] and phosphamidon [ISO])
2015-03-01	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2015-03-00	29241900	Acyclic amides, incl. acyclic carbamates, and their derivatives, and salts thereof (excl. meprobamate [INN], fluoroacetamide [ISO], monocrotophos [ISO] and phosphamidon [ISO])
2015-03-00	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2015-02-01	29241900	Acyclic amides, incl. acyclic carbamates, and their derivatives, and salts thereof (excl. meprobamate [INN], fluoroacetamide [ISO], monocrotophos [ISO] and phosphamidon [ISO])
2015-02-01	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2015-02-00	29241900	Acyclic amides, incl. acyclic carbamates, and their derivatives, and salts thereof (excl. meprobamate [INN], fluoroacetamide [ISO], monocrotophos [ISO] and phosphamidon [ISO])
2015-02-00	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2014-12-01	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2014-11-01	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2014-10-01	29241900	Acyclic amides, incl. acyclic carbamates, and their derivatives, and salts thereof (excl. meprobamate [INN], fluoroacetamide [ISO], monocrotophos [ISO] and phosphamidon [ISO])
2014-10-01	35040090	Peptones and their derivatives; other albuminous substances and their derivatives, n.e.s.; hide powder, whether or not chromed (excl. concentrated milk proteins with a protein content > 85 % by weight, calculated on the dry matter
2012-05-01	34042000	Poly"oxyethylene" [polyethylene glycol] waxes
2012-04-01	39072011	Polyethylene glycols, in primary forms
2012-03-01	29183000	Carboxylic acids with aldehyde or ketone function but without other oxygen function, their anhydrides, halides, peroxides, peroxyacids and their halogenated, sulphonated, nitrated or nitrosated derivatives
2012-01-01	39072011	Polyethylene glycols, in primary forms
2011-12-01	39072099	Polyethers in primary forms (excl. polyether alcohols, polyacetals and copolymer of 1-chloro-2,3-epoxypropane with ethylene oxide)
2011-10-01	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2011-09-01	29183000	Carboxylic acids with aldehyde or ketone function but without other oxygen function, their anhydrides, halides, peroxides, peroxyacids and their halogenated, sulphonated, nitrated or nitrosated derivatives
2011-09-01	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2011-09-01	39072011	Polyethylene glycols, in primary forms
2011-06-01	34042000	Poly"oxyethylene" [polyethylene glycol] waxes
2011-05-01	39072099	Polyethers in primary forms (excl. polyether alcohols, polyacetals and copolymer of 1-chloro-2,3-epoxypropane with ethylene oxide)
2011-01-01	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2010-12-01	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2010-11-01	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2010-10-01	39072099	Polyethers in primary forms (excl. polyether alcohols, polyacetals and copolymer of 1-chloro-2,3-epoxypropane with ethylene oxide)
2010-09-01	35079090	Enzymes and prepared enzymes, n.e.s. (excl. rennet and concentrates thereof, lipoprotein lipase and Aspergillus alkaline protease)
2010-09-01	90189085
2010-06-01	39072099	Polyethers in primary forms (excl. polyether alcohols, polyacetals and copolymer of 1-chloro-2,3-epoxypropane with ethylene oxide)

For goods imported into the United Kingdom, only imports originating from outside the EU are shown

Government Grants / Awards

Technology Strategy Board Awards

ABZENA (UK) LIMITED has been awarded 5 awards from the Technology Strategy Board. The value of these awards is £ 880,291

Category	Award Date	Award/Grant
A novel injectable sustained release delivery system for the treatment of Hepatitis C : Collaborative Research and Development	2011-09-01	£ 155,793
Snovel fusion enzymes for industrial processes : Collaborative Research and Development	2010-04-01	£ 104,700
LLOT : European	2009-09-01	£ 132,328
The expression, modification and enhancement of protein therapeutics : Department of Trade and Industry	2007-12-01	£ 136,340
An Integrated System For Fab Bioproduction : Department of Trade and Industry	2007-08-01	£ 351,130

How is this useful? The company may be investing in new products to generate new revenue streams or investing in new technologies to increase productivity / reduce costs. The company may own IPR as a result.

European Union CORDIS Awards

The European Union has not awarded ABZENA (UK) LIMITED any grants or awards.

Ownership

We could not find any group structure information

Is this data useful to you?

If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help.
Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.

Need more information?

We offer bespoke investigations into companies. If you need more information about this company we can gather more information as directed by you. This may, for example, be a forensic investigation such as tracing hidden assets. The engagement is on a time and materials basis. We charge GBP £ 500 per day + VAT. Contact us with a description of what you're looking for and we will assess whether we can help.

Last Datalog update:	2024-04-06 22:18:33
Primary Source:	Companies House

Company Overview

Company Officers of ABZENA (UK) LIMITED

Related Directorships

Trademark applications by ABZENA (UK) LIMITED